Antonio Machado Felisberto Júnior

Prof. Antonio Machado Felisberto Júnior

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SBSandra Lucinei Balbo
Sandra Lucinei Balbo
GSGabriela Soares
Gabriela Soares
JMJoseane Morari
Joseane Morari
AJAntonio Machado Felisberto Júnior
Antonio Machado Felisberto Júnior
JVJean Franciesco Vettorazzi
Jean Franciesco Vettorazzi
Licio VellosoLicio Velloso
Licio Velloso
The epidemic of obesity has increased worldwide and is associated with comorbidities such as diabetes and cardiovascular disease. In this context, strategies that modulate body weight and improve glycemic metabolism have increased, and bariatric surgeries such as Sleeve Gastrectomy (SG) have been highlighted in obesity treatment. However, the mechanism by which SG reduces body weight and improves glycemic control remains unknown. Thus, in this study, we aimed to evaluate food intake and the expression of hypothalamic genes involved with the regulation of this process in diet-induced obese mice submitted to SG. For this, we used C57BL/6 mice submitted to a 10-week high-fat diet protocol and submitted to SG. Food intake, fed and fasted glycemia, as well as hypothalamic anorexigenic and orexigenic gene expression were evaluated 4 weeks after the surgical procedure. First, we observed that SG reduces body weight (44.19 ± 0.47 HFD, 43.51 ± 0.71 HFD-SHAM, and 38.22 ± 1.31 HFD-SG), fasting glycemia (115.0 ± 4.60 HFD, 122.4 ± 3.48 HFD-SHAM, and 93.43 ± 4.67 HFD-SG), insulinemia (1.77 ± 0.15 HFD, 1.92 ± 0.27 HFD-SHAM, and 0.93 ± 0.05 HFD-SG), and leptinemia (5.86 ± 1.38 HFD, 6.44 ± 1.51 HFD-SHAM, and 1.43 ± 0.35 HFD-SG) in obese mice. Additionally, SG reduces food (5.15 ± 0.18 HFD, 5.49 ± 0.32, HFD-SHAM, and 3.28 ± 0.26 HFD-SG) and total (16.88 ± 0.88 HFD, 17.05 ± 0.42, HFD-SHAM, and 14.30 ± 0.73 HFD-SG) calorie intake without alterations in anorexigenic and orexigenic gene expression. In conclusion, these data indicate that SG improves obesity-associated alterations at least in part by a reduction in food intake. This effect is not associated with the canonical food intake pathway in the hypothalamus, indicating the involvement of non-canonical pathways in this process.

1 July 2025 in Cuadernos de Educación y Desarrollo
Verified
Journal Article
Open access
PDF file
AJAntonio Machado Felisberto Júnior
Antonio Machado Felisberto Júnior
RGRodrigo Juliano Grignet
Rodrigo Juliano Grignet
MGMaria Claudia Gross
Maria Claudia Gross
SBSandra Lucinei Balbo
Sandra Lucinei Balbo
JGJuliann Ernesto Grignet
Juliann Ernesto Grignet
JVJean Franciesco Vettorazzi
Jean Franciesco Vettorazzi
A obesidade, amplamente reconhecida como uma das principais condições associadas à resistência à insulina, tem sido descrita como uma epidemia global, demandando abordagens de tratamento multifatoriais. Nesse cenário, as cirurgias bariátricas se destacam como uma estratégia eficaz no manejo da obesidade, empregando diferentes técnicas que envolvem, em certos casos, a secção ou modulação do nervo vago, suprimindo ou regulando sinais aferentes e eferentes desregulados, comumente observados no contexto da obesidade, oferecendo assim um potencial terapêutico. Com base nessa premissa, foi conduzida uma revisão integrativa utilizando a metodologia PICO para responder à seguinte questão: "Os efeitos observados após a cirurgia bariátrica sobre o peso corporal e a homeostase glicêmica estão relacionados à modulação do nervo vago?". O objetivo principal foi examinar a literatura disponível sobre o papel das cirurgias bariátricas e a modulação do nervo vago em humanos obesos, avaliando as possíveis alterações na homeostase glicêmica e lipídica. Os estudos revisados indicam um papel crucial do nervo vago no desenvolvimento da obesidade, com evidências de que sua modulação, no contexto das intervenções cirúrgicas, promove mudanças significativas na composição corporal dos indivíduos, incluindo melhorias no controle glicêmico.

29 August 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
SBSandra Lucinei Balbo
Sandra Lucinei Balbo
GSGabriela Soares
Gabriela Soares
JMJoseane Morari
Joseane Morari
AJAntonio Machado Felisberto Júnior
Antonio Machado Felisberto Júnior
JVJean Franciesco Vettorazzi
Jean Franciesco Vettorazzi
ABAntonio Carlos Boschero
Antonio Carlos Boschero
The epidemic of obesity has increased worldwide and is associated with comorbidities as diabetes as cardiovascular disease. Strategies that modulate body weight and improves glycemic metabolism has increased, and the bariatric surgeries as Sleeve Gastrectomy (SG) has been highlighted in obesity treatment. However, the mechanism by which SG reduces body weight and improves glycemic control are unknow. C57BL mice were submitted to a 10 weeks high fat-diet protocol and submitted to SG. Food intake, fed/fasted glycemia and hypothalamic anorexigenic and orexigenic gene expression were evaluated. SG reduces body weight, fasting glycemia, insulinemia and leptinemia in obese mice. Moreover, SG reduces food and total calorie intake with no alterations in the expression of anorexigenic and orexigenic gene expression. These data indicates that SG improves obesity associated alterations, at least in part, by reduction on food intake. This effect is not associated with the classic food intake pathway in hypothalamus, indicating the involvement of supplementary pathways in this process.